Cancer Care Portal | Latest News, Research, and Support

Chris Draft Shares Steps to Assist Sufferers Regain Management After Most cancers

FDA Quick Observe Designation Highlights New Possibility in Superior Liver Most cancers

In search of a Dose of Hope Amidst Most cancers

FDA Clears Part 2b Research of Teverelix in Superior Prostate Most cancers

When Most cancers Care Turns into a Logistical Balancing Act

The Cancer

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

February 11, 2026

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

February 11, 2026

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

February 11, 2026

MRD Testing Could Supply Peace of Thoughts to Breast Most cancers Survivors

February 11, 2026

A Household’s Power Via Liver Most cancers and Residing Donation

February 11, 2026

Editor - February 12, 2026

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

February 12, 2026

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

February 11, 2026

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

February 11, 2026

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

February 11, 2026

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

February 11, 2026

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

February 11, 2026

Don't Miss

How Caregivers Can Assist Liked Ones With Lung Most cancers Really feel in Management

Household Begins AYA Most cancers Basis After Lymphoma Prognosis

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

News

Research Hyperlinks Drug Remedy to Fewer Sizzling Flashes Throughout Prostate Most cancers Care

Editor - February 9, 2026

Sizzling flashes are some of the frequent and disruptive unwanted effects skilled by males receiving androgen-deprivation remedy (ADT) for prostate most cancers. Now, outcomes from...

News

Why Breast Most cancers Care Is not One Measurement Matches All

Editor - February 9, 2026

CURE spoke with Dr. Kathie-Ann Joseph concerning the significance of personalised, multidisciplinary therapies when caring for sufferers with breast most cancers.Joseph was just lately appointed...

News

Mother of 4 Shares Story of Her Breast Most cancers Prognosis

Editor - February 9, 2026

Mary Royal, a 54-year-old mom of 4, acquired a analysis of multicentric breast most cancers in 2023, a analysis which adopted a mammogram that she...

Vital Information

News

Most cancers Anniversaries Good and Unhealthy

News

A Liver Most cancers Journey Marked by Persistence, Household and Hope

News

FDA Grants Designation to Immunotherapy KB707 for Superior NSCLC

News

Knowledgeable Explains Adjuvant Temozolomide Boosts Astrocytoma Survival

News

Residing with IDH-Mutant Glioma: Understanding Prognosis, Therapy Choices and Supportive Care

Editor - February 8, 2026

Radiation Oncologist and Breast Most cancers Survivor Shares Her Story

Editor - February 7, 2026

Merkel Cell Carcinoma: Explaining the Uncommon and Harmful Pores and skin Most cancers

Editor - February 7, 2026

Personalised Remedy Guides Lung Most cancers Look after Youthful Adults

Editor - February 7, 2026

Understanding Your Stage 3 Clear Cell Renal Cell Carcinoma Prognosis

Editor - February 7, 2026

Hodgkin Lymphoma: What Ought to Newly Recognized Sufferers Know?

Editor - February 6, 2026

The Energy of Personalised Care in Breast Most cancers Therapy

Facts

Actual-World Knowledge with Amtagvi Present Excessive Response Charges in Superior Melanoma

February 6, 2026

How Prevention and Entry Form Outcomes in Pores and skin Most cancers Care

February 6, 2026

How Mantras Impacted My Life Throughout a Colon Most cancers Journey

February 6, 2026

How Advances in Remedy Are Altering Pores and skin Most cancers Care

February 6, 2026

FDA Grants Orphan Drug Designation to Zenocutuzumab for Cholangiocarcinoma

February 6, 2026

FDA Removes Use Limitation for Yescarta in Main CNS Lymphoma

February 6, 2026

Latest Articles

News

Mutational Signatures Level to Doable Kidney Most cancers Causes

Editor - July 2, 2024

July 1, 2024, ...

1...1,667 1,6681,669Page 1,669 of 1,669

Hot Topics

FDA Updates Security Warnings for Frequent Chemotherapy Medicine

ROSELLA Trial Extends Survival in Platinum-Resistant Ovarian Most cancers

Ideas about Relapse of A number of Myeloma